WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Australia's deputy prime minister pledges support to Solomon Islands during visit to Honiara
Pic story of dancing couple in China's Xinjiang
China accelerates building of new quality productive forces
Georgia QB Jaden Rashada sues Florida coach, others over failed $14M NIL deal
Chinese, Brazilian scientists name new flying reptiles to mark collaboration
Pic story of dancing couple in China's Xinjiang
No more cute snaps of Mt Fuji. A screen is up in a Japanese town to prevent tourist crowds
Tennessee latest state to mandate automatic defibrillators at high schools
Momofuku backs down from 'chile crunch' trademark war